TABLE 2.
Mutation efficiency of the CRISPR-Cas two-plasmid systema
| Expt no. | Host cell | Plasmid pTarget | Targeting genome locus of sgRNA | Donor DNA supplied in pTarget or in PCR fragment (F) | Length (bp) of homologous extensions (upstream, downstream) | Mutation efficiency (%)b | Plasmid pTarget curing efficiency (%) |
|---|---|---|---|---|---|---|---|
| 1 | MG1655 | pTargetT-ΔcadA | cadA | pTargetT-ΔcadA | 523, 281 | 86 ± 4 | 100 |
| 2 | MG1655 | pTargetT-ΔmaeAΔmaeB | maeA, maeB | pTargetT-ΔmaeAΔmaeB | 250, 550 | 97 ± 4 | ND |
| 3 | MG1655 | pTargetT-ΔcadAΔmaeAΔmaeB | cadA, maeA, maeB | pTargetT-ΔcadAΔmaeAΔmaeB | 250, 550 | 47 ± 8 | ND |
| 4 | MG1655 | pTargetT-ΔyjcS::ybas | yjcS | pTargetT-ΔyjcS::ybaS | 373, 360 | 92 ± 0 | ND |
| 5 | MG1655 | pTargetT-ΔyjcS:: evgAS | yjcS | pTargetT-ΔyjcS::evgAS | 373, 360 | 75 ± 18 | ND |
| 6 | MG1655 | pTargetT-ΔmaeB::gltP ΔmaeA | maeB, maeA | pTargetT-ΔmaeB::gltP ΔmaeA | 250, 550 | 78 ± 26 | ND |
| 7 | 1655ΔcadAc | pTargetT-ΔyjcS::evgAS | yjcS | pTargetT-ΔyjcS::evgAS | 373, 360 | 92 ± 7 | 100 |
| 8 | MG1655 | pTargetF-cadA | cadA | ΔcadA (F) | 523, 281 | 69 ± 4 | ND |
| 9 | MG1655 | pTargetF-yjcS | yjcS | ΔyjcS::evgAS (F) | 40, 40 | 6 ± 4 | ND |
| 10 | MG1655 | pTargetF-yjcS | yjcS | ΔyjcS::evgAS (F) | 373, 360 | 28 ± 10 | ND |
| 11 | MG1655 | pTargetF-kefB-yjcS | kefB, yjcS | ΔkefB, ΔyjcS::evgAS (F) | 250, 550 | 0 | ND |
| 12 | DSM 13699 | pTargetT-ΔtkrA | tkrA | pTargetT-ΔtkrA | 483, 513 | 100 ± 0 | 100 |
| 13 | DSM 13699 ΔtkrAc | pTargetT-Δglk | glk | pTargetT-Δglk | 500, 500 | 94 ± 8 | 100 |
The genome editing was performed with the CRISPR-Cas two-plasmid system with pCAS and pTarget, as shown. ND, not determined.
Determined from triple electroporation experiments by colony PCR from 12 transformants for each mutation (agarose electrophoresis gels of colony PCR and relative sequencing results are shown in Fig. S1 and S2 in the supplemental material).
Second round of genome editing.